CHS Stock Overview
Engages in the development of customized healthcare administrative software solutions. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Comprehensive Healthcare Systems, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$0.005 |
52 Week High | CA$0.03 |
52 Week Low | CA$0.005 |
Beta | 2.17 |
11 Month Change | 0% |
3 Month Change | 0% |
1 Year Change | -75.00% |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -98.57% |
Recent News & Updates
Recent updates
Shareholder Returns
CHS | CA Healthcare Services | CA Market | |
---|---|---|---|
7D | 0% | -2.7% | 0.4% |
1Y | -75.0% | 98.2% | 21.4% |
Return vs Industry: CHS underperformed the Canadian Healthcare Services industry which returned 82.9% over the past year.
Return vs Market: CHS underperformed the Canadian Market which returned 24.6% over the past year.
Price Volatility
CHS volatility | |
---|---|
CHS Average Weekly Movement | n/a |
Healthcare Services Industry Average Movement | 8.2% |
Market Average Movement | 8.3% |
10% most volatile stocks in CA Market | 17.7% |
10% least volatile stocks in CA Market | 2.9% |
Stable Share Price: CHS has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine CHS's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | n/a | Chris Cosgrove | www.comphealthsys.com |
Comprehensive Healthcare Systems, Inc. engages in the development of customized healthcare administrative software solutions. The company offers NOVUS 360, a suite of applications, including benefits admin software, third party administrator, data and pricing transparency, medical management, pharmacy benefit management, and financial recovery. It provides licensing and maintenance services.
Comprehensive Healthcare Systems, Inc. Fundamentals Summary
CHS fundamental statistics | |
---|---|
Market cap | CA$620.12k |
Earnings (TTM) | -CA$7.05m |
Revenue (TTM) | CA$5.39m |
0.1x
P/S Ratio-0.1x
P/E RatioIs CHS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
CHS income statement (TTM) | |
---|---|
Revenue | US$4.00m |
Cost of Revenue | US$2.57m |
Gross Profit | US$1.43m |
Other Expenses | US$6.66m |
Earnings | -US$5.23m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.042 |
Gross Margin | 35.84% |
Net Profit Margin | -130.73% |
Debt/Equity Ratio | -22.8% |
How did CHS perform over the long term?
See historical performance and comparison